Education
About Us
Working with TipRanks
Follow Us
Mckesson Corp. (GB:0JZU)
LSE:0JZU
0JZU Stock Chart & Stats
Day’s Range― - ―
52-Week Range$466.12 - $736.03
Previous CloseN/A
Volume183.00
Average Volume (3M)224.00
Market Cap
$89.59B
Enterprise Value$95.53B
Total Cash (Recent Filing)$1.13B
Total Debt (Recent Filing)$9.76B
Price to Earnings (P/E)27.9
Beta0.10
Next Earnings
Jul 30, 2025EPS Estimate
8.29Next Dividend Ex-Date
Jun 02, 2025Dividend Yield0.39%
Share Statistics
EPS (TTM)10.12
Shares Outstanding125,112,236
10 Day Avg. Volume202
30 Day Avg. Volume224
Financial Highlights & Ratios
PEG Ratio2.37
Price to Book (P/B)-28.33
Price to Sales (P/S)0.00
P/FCF Ratio43.05
Enterprise Value/Market Cap1.07
Enterprise Value/Revenue0.07
Enterprise Value/Gross Profit7.38
Enterprise Value/Ebitda4.68
Forecast
1Y Price Target
$761.92Price Target Upside6.27% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
McKesson News
Bulls Say, Bears Say
Bulls Say
Operational Income GrowthThe US Pharma segment is estimated to have significant operational income growth, implying year-over-year growth of 13.7%.
Strategic GrowthManagement believes the strategic portfolio update will position the company to focus better on strategic growth areas and more effectively deploy capital.
Bears Say
Product And Pricing UncertaintyThere are limited details about the number of products that would be impacted, countries that would be included in the reference basket, impact on new product launches, which payment channels are included, and how pricing would be implemented.
Regulatory OverhangThe potential enactment of a most-favored nation (MFN) drug pricing does create a potential overhang on the space.
Options Prices
Currently, No data available
---
Ownership Overview
0.06% Insiders
23.38%
Mutual Funds
3.67% Other Institutional Investors
51.63% Public Companies and Individual Investors
0JZU FAQ
What was Mckesson Corp.’s price range in the past 12 months?
Mckesson Corp. lowest share price was $466.12 and its highest was $736.03 in the past 12 months.
What is Mckesson Corp.’s market cap?
Mckesson Corp.’s market cap is $89.59B.
When is Mckesson Corp.’s upcoming earnings report date?
Mckesson Corp.’s upcoming earnings report date is Jul 30, 2025 which is in 66 days.
How were Mckesson Corp.’s earnings last quarter?
Mckesson Corp. released its earnings results on May 08, 2025. The company reported $10.12 earnings per share for the quarter, beating the consensus estimate of $9.827 by $0.293.
Is Mckesson Corp. overvalued?
According to Wall Street analysts Mckesson Corp.’s price is currently Undervalued.
Does Mckesson Corp. pay dividends?
Mckesson Corp. pays a Quarterly dividend of $2.747 which represents an annual dividend yield of 0.39%. See more information on Mckesson Corp. dividends here
What is Mckesson Corp.’s EPS estimate?
Mckesson Corp.’s EPS estimate is 8.29.
How many shares outstanding does Mckesson Corp. have?
Mckesson Corp. has 125,112,236 shares outstanding.
What happened to Mckesson Corp.’s price movement after its last earnings report?
Mckesson Corp. reported an EPS of $10.12 in its last earnings report, beating expectations of $9.827. Following the earnings report the stock price went down -0.979%.
Which hedge fund is a major shareholder of Mckesson Corp.?
Currently, no hedge funds are holding shares in GB:0JZU
McKesson Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$761.92 (6.27% Upside)
$761.92 (6.27% Upside)
Blogger Sentiment
Bullish
GB:0JZU Sentiment 91%
Sector Average 70%
Sector Average 70%
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.91%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
11.41%
Trailing 12-Months
Company Description
Mckesson Corp.
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
0JZU Company Deck
0JZU Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong financial performance with record revenue and EPS growth, strategic acquisitions, and robust shareholder returns. However, there are challenges related to business divestitures, regulatory uncertainties, and the planned separation of the medical surgical segment.Read More>0JZU Revenue Breakdown
90.22% U.S. Pharmaceutical
4.57% International
3.66% Medical-Surgical Solutions
1.54% Prescription Technology Solutions
0JZU Stock 12 Month Forecast
Average Price Target
$761.92
▲( 6.27% Upside)